HealthXCapital
HealthXCapital is a Singapore-based early-stage venture capital fund that invests in healthcare technology startups across South East Asia and India, providing capital alongside clinical validation and commercialization support through its anchor partner network.
- Company typePrivate
- Founded2018
- HeadquartersSingapore, Singapore
- Headcount1–10
- GTM typeB2B
- OfferingServices
What HealthXCapital does
HealthXCapital is a Singapore-based, healthcare-focused early-stage venture capital platform that invests in startups across South East Asia and India. Founded in 2018 and anchored by Jungle Ventures and Apollo Hospitals, the firm operates a US$25 million fund backed by Eight Roads Ventures (Fidelity International), Enterprise Singapore, and private investors. Its investment thesis targets startups addressing healthcare access, affordability, and market-fit challenges across six thematic areas: point-of-care diagnostics and devices, home health solutions, preventive health solutions, digital health solutions, biomarkers, and AI/ML applications.
The firm's core offering is "smart connected capital," combining equity investment with clinical validation through marquee healthcare providers (notably Apollo Hospitals), commercialization support via strategic partners in insurance, medtech, and provider sectors, and follow-on capital facilitation through its investor network. HealthXCapital has invested in eight disclosed portfolio companies, including Breath Diagnostics, Child Health Imprints, Homage, Jana Care, Medfin, Praktice.ai, StanPlus, and THB. Its go-to-market relies on a curated clinical and commercial partner network rather than traditional deal sourcing, supported by a specialized advisory board featuring Dr. Daniel Kraft (Singularity University), Dr. Prem Pillay (Singapore neurosurgeon), and Dr. Arda Minocherhomjee (Chicago Growth Partners).
HealthXCapital generates returns through equity appreciation and exits (acquisitions, IPOs, secondary sales) of its portfolio holdings. Standard VC economics apply, with management fees on the committed fund and carried interest on realized gains. The firm is led by Managing Partner Seemant Jauhari, with a lean team of 1-10 employees based at 1 George Street, Singapore. Revenue, fee structure, and realized exits are not publicly disclosed.
HealthXCapital firmographics
Firmographics- Name
- HealthXCapital
- Legal name
- HealthXCapital
- Website
- https://healthxcapital.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- HealthXCapital is a Singapore-based early-stage venture capital fund that invests in healthcare technology startups across South East Asia and India, providing capital alongside clinical validation and commercialization support through its anchor partner network.
- Ownership category
- akta.pro rank
HealthXCapital industry classification
Industry- Product category
- Healthcare Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940), Open-End Investment Funds (525910)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare Access & Life Sciences Impact Funds (FSANAJAI)
- akta.pro secondary industries
- Virtual Nursing, Telemonitoring & Command Center Platforms (HLACAFAH), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
Keywords
Where HealthXCapital is headquartered
LocationHeadquarters
- HQ city
- Singapore
- HQ country
- Singapore
- HQ region
- Asia
Offices1 record
Markets served
HealthXCapital business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Others
Revenue model
- Venture Capital Returns: HealthXCapital generates returns through equity investments in early-stage healthcare startups across South East Asia and India. Returns are realized through exits via acquisitions, IPOs, or secondary sales of portfolio company equity.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
HealthXCapital product offering
Product offeringCore offering
HealthXCapital is an early-stage venture capital platform providing a $25 million fund of "smart connected capital" to healthcare technology startups in South East Asia and India. The fund combines equity investment with clinical assessment capabilities, market customization support, and commercialization pathways through its anchor partnership with Apollo Hospitals and Jungle Ventures. It invests across five interest areas: point-of-care diagnostics/devices, home health solutions, preventive health, digital health, and biomarkers with AI/ML.
Product overview
HealthXCapital is an early-stage venture capital investment platform, not a product company. It is not a SaaS or technology product provider with a unified platform or modules. Rather, it is a $25 million healthcare-focused VC fund backed by Jungle Ventures and Apollo Hospitals, providing smart connected capital, clinical insights, and commercialization support to healthcare startups in Southeast Asia and India. The firm's offering is investment capital combined with strategic advisory services, not software products. Its portfolio consists of minority stakes in independent startup companies across diagnostics, digital health, home care, and medical devices. No individual branded product or module is offered directly by HealthXCapital.
Differentiator
Problem solved
Functional benefit
Products and services
- HealthXCapital Fund A $25 million early-stage venture capital fund focused on healthcare technology startups in emerging Asian markets including Southeast Asia and India. The fund provides capital, clinical assessment, and commercialization capabilities to investee companies across point-of-care diagnostics/devices, home health solutions, preventive health, digital health solutions, and biomarkers with AI/ML.
Companies that use HealthXCapital
Customer profileNamed customers3 records
Segments1 record
Ideal customer profiles1 record
HealthXCapital technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
HealthXCapital partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core.
- Dr. Arda M. MinocherhomjeecoreSpecial Advisor and founding Partner of Chicago Growth Partners. Provides healthcare investment expertise and joined Breath Diagnostics board post-investment.
- Dr. Prem PillaycoreLeading neurosurgeon in Singapore and serial investor. Healthcare domain advisor providing clinical validation and network access.
- Dr. Daniel KraftcoreChair of Medicine at Singularity University and founder of Exponential Medicine. Provides exponential technology insights and global healthcare innovation network.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
HealthXCapital competitors and assessment
Company assessmentDirect peers
- Wavemaker Partners: Early-stage VC with a dedicated healthcare and digital health practice spanning the US and Southeast Asia, making it a direct peer in terms of stage, geography, and healthtech focus.
- Vivo Capital: Healthcare-focused investment firm with Asia exposure covering therapeutics, medical devices, and digital health, comparable to HealthXCapital's healthcare-focused venture model with regional presence.
- Verge HealthTech Fund: Early-stage healthtech venture fund focused on Southeast Asia and India, directly comparable to HealthXCapital in stage, sector focus, and geographic mandate.
- Jungle Ventures: Anchor LP and partner of HealthXCapital; a leading early-stage Singapore VC with healthcare exposure, providing a direct comparison point for fund model, stage, and Southeast Asia focus.
Regional players
- Monk's Hill Ventures: Singapore-based early-stage VC with active investments across Southeast Asia including healthcare/digital health, operating in the same geographies with overlapping portfolio focus.
- Qualgro Partners: Southeast Asia-focused early-to-growth stage VC with significant healthtech and digital health investments in Singapore and the region, operating in adjacent geographies and stages.
- East Ventures: Indonesia- and Southeast Asia-focused early-stage VC with an active healthtech portfolio, comparable in stage and regional focus though broader in sector.
Broad incumbents
- Andreessen Horowitz (a16z Bio + Health): Large global VC with a dedicated Bio + Health fund investing across healthtech, biotech, and digital health, competing for top healthtech deals in Asia and setting valuation benchmarks.
- Novo Holdings (Novo Seeds/Novo Ventures): Global healthcare-focused investment firm backing therapeutics, devices, and digital health, comparable as a healthcare-specialist investor with growing Asia presence and impact orientation.
Emerging players
- Galen Growth: Asia-focused digital health research and venture platform, comparable as an Asia healthtech ecosystem participant supporting deal flow, benchmarking, and partnerships.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
HealthXCapital social profiles
Digital presenceHealthXCapital financial estimates
Financial estimateRevenue estimate
Valuation estimate
HealthXCapital leadership team
Management profileNumber of profiles
Profiles6 records
HealthXCapital funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HealthXCapital M&A and investment
M&A and investmentM&A
Investments10 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HealthXCapital
What does HealthXCapital do?
HealthXCapital is an early-stage venture capital platform providing a $25 million fund of "smart connected capital" to healthcare technology startups in South East Asia and India. The fund combines equity investment with clinical assessment capabilities, market customization support, and commercialization pathways through its anchor partnership with Apollo Hospitals and Jungle Ventures. It invests across five interest areas: point-of-care diagnostics/devices, home health solutions, preventive health, digital health, and biomarkers with AI/ML.
Is HealthXCapital a public or private company?
HealthXCapital is a private company. It is classified as venture growth investor backed and is currently operating.
When was HealthXCapital founded?
HealthXCapital was founded in 2018. It employs 1 to 10 people.
Where is HealthXCapital based?
HealthXCapital is headquartered in Singapore, Singapore, in the Asia region.
How does HealthXCapital make money?
One revenue line is on record: venture Capital Returns.
Who are HealthXCapital's main competitors?
Direct peers on record are Wavemaker Partners, Vivo Capital, Verge HealthTech Fund and Jungle Ventures. Regional players are Monk's Hill Ventures, Qualgro Partners and East Ventures. Broad incumbents are Andreessen Horowitz (a16z Bio + Health) and Novo Holdings (Novo Seeds/Novo Ventures). Galen Growth is listed as an emerging player.
Does HealthXCapital have an API?
No public API is recorded for HealthXCapital.
What industry is HealthXCapital in?
HealthXCapital's product category is Healthcare Venture Capital. Its primary akta.pro industry code is FSANAJAI, Healthcare Access & Life Sciences Impact Funds, with a secondary code of HLACAFAH, Virtual Nursing, Telemonitoring & Command Center Platforms. Its NAICS code is 523940 and its SIC code is 6282.